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Staphylococcus aureus bacteraemia (SAB) in  
Australian public hospitals 2013–14
SAB is a serious bloodstream infection that may be associated with hospital care. Hospitals aim to have as 
few cases as possible. 
The nationally agreed benchmark is no more than 2.0 SAB cases per 10,000 days of patient care for acute 
care public hospitals in each state and territory.
In 2013–14:
•   the national rate of SAB in public  
hospitals was 0.87 cases per 10,000 days 
of patient care
•   rates differed among the states and 
territories, but all jurisdictions had  
rates below the national benchmark
•  1,621 cases of SAB were reported 
•   3 in 4 cases were treatable with 
commonly used antibiotics  
—methicillin-sensitive Staphylococcus 
aureus (MSSA) cases
•   1 in 4 cases was antibiotic resistant—
methicillin-resistant Staphylococcus aureus 
(MRSA) cases.
Between 2010–11 and 2013–14, rates of SAB 
decreased from 1.10 cases to 0.87 cases  
per 10,000 days of patient care.  
The overall number of SAB cases decreased from 
1,876 in 2010–11 to 1,621 cases in 2013–14.  
The number of MRSA cases decreased from 505  
to 389 cases. 
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Introduction
This report presents the fourth year of nationally consistent information on cases of Staphylococcus aureus 
bacteraemia (SAB) associated with public hospitals in Australia. It contributes to ongoing robust national and 
jurisdictional arrangements to monitor and reduce SAB. 
The report presents national information on cases of SAB associated with care provided by public hospitals for the 
period 1 July 2013 to 30 June 2014. In addition, summary data for the previous 3 years are included. SAB cases were 
defined as outlined in Box 1. The data were provided by states and territories to the Australian Institute of Health 
and Welfare (AIHW).
What is Staphylococcus aureus bacteraemia?
SAB is a type of infection often associated with 
healthcare. It occurs when Staphylococcus aureus 
bacteria (‘Golden staph’) cause an infection of the 
bloodstream (bacteraemia). When associated with 
healthcare procedures, these infections are  
considered to be potentially preventable.
Patients who develop bloodstream infections  
such as SAB are more likely to suffer complications  
that result in longer stays in hospital, and the most 
serious infections can result in death. They also  
result in potentially unnecessary increases in the  
cost of hospitalisation.
The bacteria causing SAB are frequently found on 
the skin or in the nose of many individuals and are 
commonly spread from person to person in the 
community. In this form, they are usually harmless and 
most people are unaware that they are carrying them.
In hospitals, transmission is most commonly via the 
hands of healthcare workers. Bacteria from the patient’s 
skin or from the hand of a healthcare worker can gain 
direct entry into the patient’s bloodstream if they have 
open wounds or when intravascular devices, such 
central or peripheral venous catheters, are inserted.
Who is at risk?
Patients who have a greater risk of infection than the 
general public are those with:
•  open wounds
•  invasive devices such as catheters
•   weakened immune systems (associated with cancer, 
or with transplant receipt, or with being very young  
or elderly)
•   chronic disease such as diabetes or severe  
underlying illness
•  prolonged or recurrent exposure to antibiotics.
Box 1: Staphylococcus aureus bacteraemia (SAB) cases
A case (patient episode) of SAB is defined as a positive blood culture for Staphylococcus aureus. For 
surveillance purposes, only the first isolate per patient is counted, unless at least 14 days has passed without 
a positive blood culture, after which an additional episode is recorded. 
A case of SAB will be considered to be healthcare-associated if: the first positive blood culture is collected 
more than 48 hours after hospital admission or less than 48 hours after discharge, or, if the first positive 
blood culture is collected 48 hours or less after admission and one or more of the following key clinical 
criteria was met for the patient episode of SAB:
•   SAB is a complication of the presence of an indwelling medical device (for example, intravascular line, 
haemodialysis vascular access, cerebrospinal fluid shunt, urinary catheter).
•  SAB occurs within 30 days of a surgical procedure where the SAB is related to the surgical site.
•  SAB was diagnosed within 48 hours of a related invasive instrumentation or incision.
•  SAB is associated with neutropenia (<1 × 109) contributed to by cytotoxic therapy.
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SAB resistance to antibiotics
Antibiotic resistance can be defined as the ability of 
bacteria to survive and even replicate during a course  
of treatment with a specific antibiotic.
A SAB that is identified by a laboratory as being caused 
by methicillin-resistant Staphylococcus aureus is referred 
to as SAB caused by MRSA. SAB caused by MRSA may 
cause more harm to patients and is associated with 
poorer outcomes as there are fewer antibiotics available 
to treat the infection.
A SAB that is identified by a laboratory as being caused 
by Staphylococcus aureus that is sensitive to commonly 
used antibiotics is referred to as SAB caused by MSSA.
Box 2: National Healthcare Agreement performance indicator: Healthcare associated infections 
The National Healthcare Agreement performance indicator is calculated using:
•   the number of SAB patient episodes associated with public hospitals (both hospitals focussing on acute 
care and hospitals focussing on care such as rehabilitation), and
•  the number of days of patient care for the public hospitals included in the SAB surveillance arrangements.
The performance indicator includes data on:
•   counts of cases of SAB, with data presented separately for methicillin-resistant (MRSA) and  
methicillin-sensitive (MSSA) SAB cases.
•   the rate of cases of SAB per 10,000 days of patient care for public hospitals included in the SAB surveillance 
arrangements. 
Data are restricted to cases associated with care provided in public hospitals. Cases that are associated 
with care provided by private hospitals and with non-hospital care are excluded (even if the patients are 
subsequently treated for the SAB in a public hospital).
The detailed specification for the performance indicator is available on the AIHW website at  
<http://meteor.aihw.gov.au/content/index.phtml/itemId/517636>.
SAB is an indicator of the safety and quality of  
hospital care
In 2008, Australian health ministers endorsed the reporting of data on SAB cases occurring in public hospitals by 
states and territories as part of performance reporting under the National Healthcare Agreement (NHA). See Box 2.
The NHA sets out objectives for the Australian, state and territory governments for health care services and  
includes the outcome area Australians receive appropriate high quality and affordable hospital and hospital-related 
care. A performance benchmark for public hospital-associated SAB is included for that outcome area:
The rate of SAB (including MRSA) is no more than 2.0 per 10,000 occupied bed days for acute 
care public hospitals by 2011–12 in each state and territory. 
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There were 1,621 cases  
of SAB in public hospitals 
in 2013–14
•   There were 1,621 cases of SAB reported in  
Australian public hospitals in 2013–14 (Table 1).
•   About 76% of cases were methicillin-sensitive  
and therefore treatable with commonly  
used antibiotics.
•   The reported SAB cases occurred during  
18.6 million days of patient care under  
surveillance during 2013–14, or 98% of days of  
patient care in public hospitals.
SAB rates were lower 
than the national 
benchmark in 2013–14
•   The national rate was 0.87 cases per 10,000 days of 
patient care (Table 1).
•   Nationally, and for each state and territory, the rate  
of SAB was lower than the national benchmark of  
2.0 per 10,000 days of patient care.
•   The rates of SAB ranged from 0.56 in South Australia  
to 1.05 in the Northern Territory.
Table 1: Cases of Staphylococcus aureus bacteraemia (SAB) in public hospitals, MRSA and MSSA,  
states and territories, 2013–14(a)
NSW Vic Qld WA SA Tas ACT NT Total
SAB cases
Methicillin-resistant Staphylococcus aureus 180 95 46 24 24 3 6 11 389
Methicillin-sensitive Staphylococcus aureus 409 307 258 124 57 32 23 22 1,232
Total 589 402 304 148 81 35 29 33 1,621
SAB cases per 10,000 days of patient care
Methicillin-resistant Staphylococcus aureus 0.28 0.20 0.14 0.15 0.17 0.08 0.17 0.35 0.21
Methicillin-sensitive Staphylococcus aureus 0.64 0.65 0.77 0.79 0.39 0.82 0.66 0.70 0.66
Total 0.92 0.85 0.90 0.94 0.56 0.90 0.84 1.05 0.87
Days of patient care under SAB surveillance (‘000) 6,414 4,745 3,362 1,577 1,454 390 347 316 18,603
Coverage (per cent) 98 99 99 95 95 100 100 100 98
(a)  See ‘Data quality summary’ in this report and the Data Quality Statement accompanying this report online.
Source: AIHW National Staphylococcus aureus Bacteraemia Data Collection.
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Table 2: Cases of Staphylococcus aureus bacteraemia (SAB) in public hospitals, MRSA and MSSA,  
2010–11 to 2013–14(a)
2010–11 2011–12 2012–13 2013–14
SAB cases 
Methicillin-resistant Staphylococcus aureus 505 424 391 389
Methicillin-sensitive Staphylococcus aureus 1,371 1,317 1,330 1,232
Total cases 1,876 1,741 1,721 1,621
SAB cases per 10,000 days of patient care
Methicillin-resistant Staphylococcus aureus 0.30 0.23 0.21 0.21
Methicillin-sensitive Staphylococcus aureus 0.80 0.70 0.70 0.66
Total SAB cases per 10,000 days 1.10 0.93 0.91 0.87
Days of patient care under surveillance (‘000) 17,081 18,731 18,934 18,603
Coverage of days of patient care under surveillance (per cent) 92 96 97 98
(a)  See ‘Data quality summary’ in this report and the Data Quality Statement accompanying this report online.
Source: AIHW National Staphylococcus aureus Bacteraemia Data Collection. 
SAB cases and rates have 
decreased over time
Between 2010–11 and 2013–14:
•   The number of SAB cases reported for Australian 
public hospitals decreased by 14%, from 1,876 to 
1,621 cases (Table 2).
•   The national rates of SAB decreased from 1.10 cases 
per 10,000 days of patient care under surveillance to 
0.87 cases per 10,000.
•   Rates decreased in New South Wales and South 
Australia, and fluctuated or remained about the  
same in the other states and territories (Figure 1).
•   The number of MRSA cases decreased from 505 to 
389 cases, and the proportion of all SAB cases that 
were MRSA decreased from 27% to 24% of the total.
•   Coverage of the data collection (days of patient care 
under surveillance compared with all days of patient 
care) increased from 92% to 98%.
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Figure 1: Staphylococcus aureus bacteraemia rates in public hospitals, states and territories, 
2010–11 to 2013–14
SAB rates vary by type  
of hospital
In 2013–14, about 55% of all SAB cases occurred in 
Principal referral hospitals and 29% occurred in Public 
acute group A hospitals. These two hospital peer groups 
together accounted for about 65% of days of patient 
care under surveillance. 
In 2013–14, SAB rates were highest for Principal referral 
hospitals, followed by Public acute group A hospitals.
Principal referral hospitals provide a very broad range of 
services, have a range of highly specialised service units, 
and have very large patient volumes. The term ‘referral’ 
recognises that these hospitals have specialist facilities 
not typically found in smaller hospitals. 
Public acute group A hospitals generally provide a wide 
range of services, but narrower than Principal referral 
hospitals. While complex patients may be treated, they 
are usually less complex than those seen in Principal 
referral hospitals.
Hence, these two hospital groups could be more  
likely to treat patients at risk of SAB than other hospital 
peer groups.
Between 2010–11 and 2013–14, SAB rates decreased for 
Principal referral hospitals and were relatively stable for 
hospitals in other peer groups (Figure 2).
For more information on public hospital peer groups 
see Australian hospital statistics 2012–13 (AIHW 2014a) 
and Australian hospital peer groups (AIHW forthcoming).
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Figure 2: Staphylococcus aureus bacteraemia rates in public hospitals, by peer group,  
2010–11 to 2013–14 
What is Australia doing  
to reduce SAB?
Healthcare-associated infections (HAIs) have been 
nominated as a priority area by the Australian Commission 
on Safety and Quality in Health Care (ACSQHC).
Consistent with the public health importance of 
HAIs, a range of national and local initiatives have 
been established throughout Australia to reduce the 
occurrence of SAB, with leadership provided by the 
ACSQHC (see Box 3).
These initiatives have been accompanied by the 
establishment of surveillance arrangements in public 
hospitals to monitor HAIs, and the development of an 
agreed national definition for cases of SAB (see Box 1).
These developments mean that nationally  
consistent data on public hospital-associated  
SAB cases can be reported. 
Hand hygiene
Improvements in the hand hygiene of healthcare 
workers is the highest priority area to reduce the risk  
of HAIs (HHA 2014).
Hand hygiene in hospitals generally refers to the 
washing and/or use of alcohol-based rubs by healthcare 
workers to clean their hands, and should be performed 
according to the World Health Organization’s ‘Five 
Moments for Hand Hygiene’ (WHO 2014).
Between July 2009 and June 2014, hand hygiene 
compliance in public hospitals increased from about 
64.1% to 81.0% (Figure 3).
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Box 3: Australian Commission on Safety and Quality in Health Care initiatives relating to SAB
The ACSQHC plays a major role in national improvements in safety and quality in healthcare, which includes 
reducing HAIs (ACSQHC 2014a). 
A number of strategies have been introduced to reduce healthcare-associated infections, including SAB 
(ACSQHC 2014b):
•   National Safety and Quality Health Service (NSQHS) Standards—a set of 10 Standards introduced 
for accreditation of all Australian health services. Standard 3: Preventing and Controlling Healthcare 
Associated Infections aims to prevent patients acquiring preventable HAIs, including SAB infections.
•   National infection control guidelines—these evidence-based guidelines provide hospitals with guidance 
on how to prevent and control infections, including SAB. They include information on managing medical 
devices, such as cannulas and catheters.
•   National standard definition for measuring SAB—ensuring surveillance of SAB infection is measured and 
reported in the same way in all public hospitals.
•   National Hand Hygiene Initiative—educating and promoting change among all healthcare providers in 
Australia. Through this initiative, the ACSQHC supports an audit and reporting process for hospitals to 
measure how they are performing. Good hand hygiene is an important strategy in reducing preventable 
infections such as SAB. 
•   Antimicrobial Stewardship Clinical Care Standard—providing guidance on delivering appropriate care 
when prescribing antibiotics. 
Figure 3: Hand hygiene compliance rates for public hospitals, July 2009 to June 2014
Source: HHA 2014.
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Data collection
The data on cases of SAB associated with public 
hospitals were collected by hospital staff for hospital 
infection surveillance. Without their work, the data 
would not have been available for this report.
The preparation of this report would also not have 
been possible without the cooperation of the state 
and territory health authorities which provided these 
data to the AIHW for national collation as the National 
Staphylococcus aureus Bacteraemia Data Collection 
(NSABDC). States and territories also provided data on 
days of patient care (sourced from data on admitted 
patient care), for the rate calculations. 
Data quality summary
This section presents a summary of information relevant 
to interpreting the data sourced from the NSABDC:
•   The NSABDC is a data set that includes counts of 
cases of SAB for each public hospital covered by SAB 
surveillance arrangements, and for private hospitals 
that choose to provide data.
•   Cases of SAB have been reported by all states and 
territories using the nationally agreed case definition.
•   There may be imprecise exclusion of some SAB cases 
due to the inherent difficulties in determining the 
origins of SAB episodes, such as those originating in 
non-hospital health care settings.
•   The days of patient care and coverage data may be 
preliminary for some hospitals or jurisdictions.
•   For some states and territories, there is less than 100% 
coverage of public hospitals. Data have not been 
adjusted for under-coverage.
•   The accuracy and comparability of the rates of 
SAB among jurisdictions and over time are also 
limited because the count of days of patient care 
(denominator) reflects the amount of admitted 
patient activity, but does not reflect the amount of 
non-admitted patient activity.
•   The data for 2013–14 are generally comparable with 
those from 2012–13 and 2011–12. 
•   The data for 2010–11 are generally comparable with 
data for other periods, except for Queensland. For 
2010–11, Queensland data were provided only for 
patients aged 14 and older. 
•   New South Wales provided the number of occupied 
bed days, rather than days of patient care under 
surveillance. The comparability of New South Wales 
data and data from other jurisdictions is therefore 
limited by the small extent that counts of occupied 
bed days would be expected to differ from counts of 
days of patient care as used in this report.
•   Due to changes in the performance indicator 
specification and data revisions by jurisdictions, the 
data presented in this report for 2010–11 to 2012–13 
differ from the data published in earlier AIHW reports 
on this subject (AIHW 2011, 2013a and 2013b).
•   The data presented have not been adjusted for 
differences in casemix among the states and 
territories or among hospital peer groups. Casemix is 
a term that refers to the range and types of patients 
treated by a hospital or other health service. For SAB, 
relevant aspects of casemix (that affect the risk of SAB 
for patients) could include patient comorbidities and 
procedures performed.
A comprehensive data quality statement for the  
2013–14 NSABDC collection is available at  
<http://meteor.aihw.gov.au>.
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In 2013–14, 1,621 cases of hospital-associated 
Staphylococcus aureus bacteraemia (SAB) were 
reported in Australian public hospitals. The national 
rate of SAB in public hospitals was 0.87 cases  
per 10,000 days of patient care, and all states and 
territories had rates below the national benchmark of 
2.0 cases per 10,000 days of patient care. 
Between 2010–11 and 2013–14, rates of SAB 
decreased from 1.10 cases to 0.87 cases per 10,000 
days of patient care.
